This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Scott M. Grundy, MD, PhD
University of Texas Southwestern Medical Center at Dallas

JAMA. 1994;271(2):101-102.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—Dr Rubins takes the summary of the Adult Treatment Panel II report to task for being inadequately documented. The full report, which draws on a very large body of evidence in arriving at its recommendations and contains 640 references, was too lengthy to be published in JAMA but will be published elsewhere.¹ The summary could not have reflected the extensive documentation of the full report.

Dr Rubins questions the target of a LDL cholesterol level of 100 mg/dL (2.6 mmol/L) or lower for patients with CHD. A lower target for LDL cholesterol was set for such patients because of the very high risk for recurrence of CHD events and because clinical trial evidence shows that cholesterol lowering significantly reduces recurrent CHD. More aggressive therapy for LDL lowering in secondary prevention than in primary prevention thus seems reasonable. The target of 100 mg/dL (2.6 mmol/L) or lower is . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?